ATI PHARMACOLOGY PROCTORED
EXAM STUDY GUIDE QUESTIONS WITH
ACTUAL SOLUTIONS 2025
a nnnurse nnis nnpreparing nnto nnadminister nna nndrug nnto nna nnclient. nnIn nnwhich nnof nnthe nnfollowing
nnsections nnof nna nndrug nnhandbook nnshould nnthe nnnurse nnlook nnto nndetermine nnif nnthe nndrug
nnhas nnmore nnthan nnone nnuse?
-adverse nneffects nn
-indications nn
-pharmacokinetics
-nursing nnimplications nn- nnANSWER: nnindications
a nnnurse nnis nnreviewing nna nndrug nnhandbook nnprior nnto nnadministering nna nndrug nnto nna nnclient
nnwho nnhas nnkidney nndisease. nnThe nnhandbook nnstates nnthat nnthe nndrug nncan nnbe
nnadministered nnbut nnidentifies nncertain nnrisks. nnWhich nnof nnthe nnfollowing nnterms nndescribes
nnthese nnrisks? nn
contraindications nn
precautions nn
paradoxical nneffects nn
adverse nneffects nn- nnANSWER: nnprecautions
a nnnurse nnis nncaring nnfor nna nnclient nnwho nnis nntaking nndiphenhydramine nnfor nninsomnia nnand
nnreports nndrowsiness. nnThe nnnurse nnshould nnidentify nnthat nndrowsiness nnindicates nnwhich
nnof nnthe nnfollowing?
therapeutic nneffect
adverse nnreaction
contraindication
,precaution nn- nnANSWER: nntherapeutic nneffect
a nnnurse nnis nnproviding nnteaching nnfor nna nnclient nnwho nnhas nna nnnew nnprescription nnfor nna
nndrug nnwith nna nnhigh nnpotential nnfor nntoxicity. nnWhich nnof nnthe nnfollowing nninformation nnshould
nnthe nnnurse nninclude? nn(Select nnall nnthat nnapply)
1. nnperiodic nnlab nntests nnare nnessential nnto nnmeasure nnserum nndrug nnlevels
2. nnmonitoring nnfor nnindications nnof nntoxicity nnis nnimportant nn
3. nntaking nnthe nndrug nnwith nnan nninducing nnagent nnwill nnincrease nnthe nnpossibility nnof nntoxicity nn
4. nntaking nnthe nnsmallest nneffective nndose nnis nncrucial
5. nnincreasing nnfluid nnintake nnis nnrecommended nnto nnavoid nntoxicity nn- nnANSWER: nn1,2,4
a nnnurse nnis nnproviding nnteaching nnto nna nnpregnant nnclient nnwho nnis nntaking nncaptopril, nnan
nnACE nninhibitor, nnto nntreat nnhypertension. nnThe nnnurse nninforms nnthe nnclient nnthat nncaptopril
nnis nna nnteratogenic nndrug. nnThe nnnurse nnshould nnexplain nnthat nnteratogenic nndrugs nncan
nncause nnwhich nnof nnthe nnfollowing?
maternal nnbleeding
maternal nnblood nnclots nn
gestational nndiabetes nn
fetal nnmalformation nn- nnANSWER: nnfetal nnmalformation
when nnreviewing nna nnlists nnof nndrugs nnin nna nndrug nnhandbook, nna nnnurse nncan nnidentify nnthe
nngeneric nnname nnfor nna nndrug nnin nnwhich nnof nnthe nnfollowing nnways?
it nnbegins nnwith nna nnlower nncase nnletter nn
it nnis nnlisted nnin nnparentheses nnalong nnwith nnthe nntrade nnname nn
there nnare nnboth nnletters nnand nnnumbers nnin nnthe nnname nn
the nnchemical nnname nnis nnlisted nnin nnparentheses nnbefore nnthe nngeneric nnname nn-
nnANSWER: nnlower nncase nnletter
a nnnurse nnis nnreviewing nna nndrug nnreference. nnThe nnnurse nnshould nnidentify nnthat nndrugs nnin
nnthe nnsame nnclass nnshare nnwhich nnof nnthe nnfollowing nnsimilarities?
they nnhave nnsimilar nnmechanisms nnof nnactions nn
,they nnhave nnthe nnsame nnhalf nnlife nn
they nnare nnadministered nnby nnthe nnsame nnroute
they nnhave nnsimilar nnavailability nn- nnANSWER: nn1
a nnnurse nnis nncaring nnfor nna nnclient nnwho nnis nnnewly nnadmitted nnto nnthe nnfacility nnfor nnchest
nnpain. nnAt nnwhich nnof nnthe nnfollowing nntimes nnshould nnthe nnnurse nnbegin nnteaching nnabout
nndrugs nnand nndischarge nnplanning?
after nnthe nnclient nnhas nna nndefinitive nndiagnosis
on nnthe nnday nnof nndischarge nn
when nnthe nnclient's nnfamily nnmembers nnare nnpresent nn
as nnsoon nnas nnpossible nn- nnANSWER: nnASAP
a nnnurse nnis nncaring nnfor nna nnclient nnwho nnis nntaking nnacetaminophen nnand nncodeine nnfor nnpain
nnrelief. nnThese nnanalgesic nndrugs nninteract nnwith nnone nnanother nnto nncause nnan nnadditive
nneffect. nnThe nnnurse nnshould nnidentify nnthat nnwhich nnof nnthe nnfollowing nncharacteristics nnof
nnadditive nndrug nninteractions? nn(select nnall nnthat nnapply)
1. nnclients nncan nnachieve nndesired nneffects nnwith nnthe nnuse nnof nnlower nndosages nn
2. nntaking nnthe nntwo nndrugs nntogether nncan nnreduce nnthe nneffects nnof nnone nnor nnboth nndrugs nn
3. nntaking nnthe nntwo nndrugs nntogether nncan nnpotentiate nnthe nneffects nnof nnone nnor nnboth
nndrugs. nn
4. nnthe nntwo nndrugs nncan nnproduce nnan nnaction nnneither nnwould nnhave nnproduced nnalone nn
5. nnboth nndrugs nnhave nnsimilar nnactions nn- nnANSWER: nn1,5
a nnnurse nnis nncaring nnfor nna nnclient nnwho nnarrived nnat nnan nnER nndepartment nnfollowing nna nnbee
nnsting. nnWhich nnof nnthe nnfollowing nnfindings nnindicates nnan nnanaphylactic nnreaction? nn(Select
nnall nnthat nnapply)
1. nnLow nnbp
2. nnwheezing nn
3. nnbradycardia
4. nnperipheral nnedema nn
, 5. nndifficulty nnswallowing nn- nnANSWER: nn1,2,5
a nnnurse nnis nnpreparing nnto nnteach nna nnclient nnhow nnto nntake nncare nnof nna nnnewly nncreated
nncolostomy. nnThe nnnurse nnshould nnidentify nnthat nnwhich nnof nnthe nnfollowing nnfactors nncan
nndecrease nnthe nnclient's nnability nnto nnlearn? nn(select nnall nnthat nnapply)
1. nnimpaired nncognitive nnlevel
2. nnlanguage nnbarrier
3. nndiscomfort nn
4. nnrepetition nnof nnteaching nn
5. nnunreadiness nnto nnlearn nn- nnANSWER: nn1,2,3,5
a nnnurse nnis nnteaching nna nnclient nnabout nnthe nnadverse nneffects nnof nndigoxin. nnWhich nnof nnthe
nnfollowing nnstatements nnshould nnthe nnnurse nninclude nnin nnthe nnteaching?
adverse nneffects nnare nnintended nneffects nnof nnthe nnmed
adverse nneffects nnindicate nna nnsevere nnallergy nnto nnthe nnmed nn
decrease nnyour nnmed nndose nnif nnadverse nneffects nnoccur nn
contact nnyour nnprovider nnif nnadverse nneffects nnoccur nn- nnANSWER: nncontact nnhcp
a nnnurse nnis nnobtaining nna nnclient's nnhealth nnhistory. nnThe nnclient nnreports nnno nnallergies nnbut
nnhas nnexperienced nnmild nnitching nnwhile nntaking nnamoxicillin nnin nnthe nnpast. nnWhich nnof nnthe
nnfollowing nnresponses nnshould nnthe nnnurse nnmake?
itching nnis nnan nnexpected nnadverse nneffect nnof nnamoxicillin
itching nncan nnindicate nnamoxicillin nntoxicity nn
itching nncan nnindicate nnhypersensitivity nnto nnamoxicillin nn
itching nncan nnresult nnfrom nndry nnskin nnwhich nnis nnoften nncaused nnby nnamoxicillin nn-
nnANSWER: nn3
a nnnurse nnis nncaring nnfor nna nnclient nnwho nnwas nnprescribed nnan nnantidepressant nnbased nnon
nnits nnability nnto nnprevent nnthe nnreuptake nnof nnneurotransmitters. nnthe nnnurse nnshould nnidentify
nnthat nnwhich nnof nnthe nnfollowing nnterms nndescribes nnwhy nnthis nndrug nnwas nnprescribed nnto
nnthe nnclient?
pharmacological nnaction
EXAM STUDY GUIDE QUESTIONS WITH
ACTUAL SOLUTIONS 2025
a nnnurse nnis nnpreparing nnto nnadminister nna nndrug nnto nna nnclient. nnIn nnwhich nnof nnthe nnfollowing
nnsections nnof nna nndrug nnhandbook nnshould nnthe nnnurse nnlook nnto nndetermine nnif nnthe nndrug
nnhas nnmore nnthan nnone nnuse?
-adverse nneffects nn
-indications nn
-pharmacokinetics
-nursing nnimplications nn- nnANSWER: nnindications
a nnnurse nnis nnreviewing nna nndrug nnhandbook nnprior nnto nnadministering nna nndrug nnto nna nnclient
nnwho nnhas nnkidney nndisease. nnThe nnhandbook nnstates nnthat nnthe nndrug nncan nnbe
nnadministered nnbut nnidentifies nncertain nnrisks. nnWhich nnof nnthe nnfollowing nnterms nndescribes
nnthese nnrisks? nn
contraindications nn
precautions nn
paradoxical nneffects nn
adverse nneffects nn- nnANSWER: nnprecautions
a nnnurse nnis nncaring nnfor nna nnclient nnwho nnis nntaking nndiphenhydramine nnfor nninsomnia nnand
nnreports nndrowsiness. nnThe nnnurse nnshould nnidentify nnthat nndrowsiness nnindicates nnwhich
nnof nnthe nnfollowing?
therapeutic nneffect
adverse nnreaction
contraindication
,precaution nn- nnANSWER: nntherapeutic nneffect
a nnnurse nnis nnproviding nnteaching nnfor nna nnclient nnwho nnhas nna nnnew nnprescription nnfor nna
nndrug nnwith nna nnhigh nnpotential nnfor nntoxicity. nnWhich nnof nnthe nnfollowing nninformation nnshould
nnthe nnnurse nninclude? nn(Select nnall nnthat nnapply)
1. nnperiodic nnlab nntests nnare nnessential nnto nnmeasure nnserum nndrug nnlevels
2. nnmonitoring nnfor nnindications nnof nntoxicity nnis nnimportant nn
3. nntaking nnthe nndrug nnwith nnan nninducing nnagent nnwill nnincrease nnthe nnpossibility nnof nntoxicity nn
4. nntaking nnthe nnsmallest nneffective nndose nnis nncrucial
5. nnincreasing nnfluid nnintake nnis nnrecommended nnto nnavoid nntoxicity nn- nnANSWER: nn1,2,4
a nnnurse nnis nnproviding nnteaching nnto nna nnpregnant nnclient nnwho nnis nntaking nncaptopril, nnan
nnACE nninhibitor, nnto nntreat nnhypertension. nnThe nnnurse nninforms nnthe nnclient nnthat nncaptopril
nnis nna nnteratogenic nndrug. nnThe nnnurse nnshould nnexplain nnthat nnteratogenic nndrugs nncan
nncause nnwhich nnof nnthe nnfollowing?
maternal nnbleeding
maternal nnblood nnclots nn
gestational nndiabetes nn
fetal nnmalformation nn- nnANSWER: nnfetal nnmalformation
when nnreviewing nna nnlists nnof nndrugs nnin nna nndrug nnhandbook, nna nnnurse nncan nnidentify nnthe
nngeneric nnname nnfor nna nndrug nnin nnwhich nnof nnthe nnfollowing nnways?
it nnbegins nnwith nna nnlower nncase nnletter nn
it nnis nnlisted nnin nnparentheses nnalong nnwith nnthe nntrade nnname nn
there nnare nnboth nnletters nnand nnnumbers nnin nnthe nnname nn
the nnchemical nnname nnis nnlisted nnin nnparentheses nnbefore nnthe nngeneric nnname nn-
nnANSWER: nnlower nncase nnletter
a nnnurse nnis nnreviewing nna nndrug nnreference. nnThe nnnurse nnshould nnidentify nnthat nndrugs nnin
nnthe nnsame nnclass nnshare nnwhich nnof nnthe nnfollowing nnsimilarities?
they nnhave nnsimilar nnmechanisms nnof nnactions nn
,they nnhave nnthe nnsame nnhalf nnlife nn
they nnare nnadministered nnby nnthe nnsame nnroute
they nnhave nnsimilar nnavailability nn- nnANSWER: nn1
a nnnurse nnis nncaring nnfor nna nnclient nnwho nnis nnnewly nnadmitted nnto nnthe nnfacility nnfor nnchest
nnpain. nnAt nnwhich nnof nnthe nnfollowing nntimes nnshould nnthe nnnurse nnbegin nnteaching nnabout
nndrugs nnand nndischarge nnplanning?
after nnthe nnclient nnhas nna nndefinitive nndiagnosis
on nnthe nnday nnof nndischarge nn
when nnthe nnclient's nnfamily nnmembers nnare nnpresent nn
as nnsoon nnas nnpossible nn- nnANSWER: nnASAP
a nnnurse nnis nncaring nnfor nna nnclient nnwho nnis nntaking nnacetaminophen nnand nncodeine nnfor nnpain
nnrelief. nnThese nnanalgesic nndrugs nninteract nnwith nnone nnanother nnto nncause nnan nnadditive
nneffect. nnThe nnnurse nnshould nnidentify nnthat nnwhich nnof nnthe nnfollowing nncharacteristics nnof
nnadditive nndrug nninteractions? nn(select nnall nnthat nnapply)
1. nnclients nncan nnachieve nndesired nneffects nnwith nnthe nnuse nnof nnlower nndosages nn
2. nntaking nnthe nntwo nndrugs nntogether nncan nnreduce nnthe nneffects nnof nnone nnor nnboth nndrugs nn
3. nntaking nnthe nntwo nndrugs nntogether nncan nnpotentiate nnthe nneffects nnof nnone nnor nnboth
nndrugs. nn
4. nnthe nntwo nndrugs nncan nnproduce nnan nnaction nnneither nnwould nnhave nnproduced nnalone nn
5. nnboth nndrugs nnhave nnsimilar nnactions nn- nnANSWER: nn1,5
a nnnurse nnis nncaring nnfor nna nnclient nnwho nnarrived nnat nnan nnER nndepartment nnfollowing nna nnbee
nnsting. nnWhich nnof nnthe nnfollowing nnfindings nnindicates nnan nnanaphylactic nnreaction? nn(Select
nnall nnthat nnapply)
1. nnLow nnbp
2. nnwheezing nn
3. nnbradycardia
4. nnperipheral nnedema nn
, 5. nndifficulty nnswallowing nn- nnANSWER: nn1,2,5
a nnnurse nnis nnpreparing nnto nnteach nna nnclient nnhow nnto nntake nncare nnof nna nnnewly nncreated
nncolostomy. nnThe nnnurse nnshould nnidentify nnthat nnwhich nnof nnthe nnfollowing nnfactors nncan
nndecrease nnthe nnclient's nnability nnto nnlearn? nn(select nnall nnthat nnapply)
1. nnimpaired nncognitive nnlevel
2. nnlanguage nnbarrier
3. nndiscomfort nn
4. nnrepetition nnof nnteaching nn
5. nnunreadiness nnto nnlearn nn- nnANSWER: nn1,2,3,5
a nnnurse nnis nnteaching nna nnclient nnabout nnthe nnadverse nneffects nnof nndigoxin. nnWhich nnof nnthe
nnfollowing nnstatements nnshould nnthe nnnurse nninclude nnin nnthe nnteaching?
adverse nneffects nnare nnintended nneffects nnof nnthe nnmed
adverse nneffects nnindicate nna nnsevere nnallergy nnto nnthe nnmed nn
decrease nnyour nnmed nndose nnif nnadverse nneffects nnoccur nn
contact nnyour nnprovider nnif nnadverse nneffects nnoccur nn- nnANSWER: nncontact nnhcp
a nnnurse nnis nnobtaining nna nnclient's nnhealth nnhistory. nnThe nnclient nnreports nnno nnallergies nnbut
nnhas nnexperienced nnmild nnitching nnwhile nntaking nnamoxicillin nnin nnthe nnpast. nnWhich nnof nnthe
nnfollowing nnresponses nnshould nnthe nnnurse nnmake?
itching nnis nnan nnexpected nnadverse nneffect nnof nnamoxicillin
itching nncan nnindicate nnamoxicillin nntoxicity nn
itching nncan nnindicate nnhypersensitivity nnto nnamoxicillin nn
itching nncan nnresult nnfrom nndry nnskin nnwhich nnis nnoften nncaused nnby nnamoxicillin nn-
nnANSWER: nn3
a nnnurse nnis nncaring nnfor nna nnclient nnwho nnwas nnprescribed nnan nnantidepressant nnbased nnon
nnits nnability nnto nnprevent nnthe nnreuptake nnof nnneurotransmitters. nnthe nnnurse nnshould nnidentify
nnthat nnwhich nnof nnthe nnfollowing nnterms nndescribes nnwhy nnthis nndrug nnwas nnprescribed nnto
nnthe nnclient?
pharmacological nnaction
